the sun malaysia ipaper logo 150x150
Thursday, July 2, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

TPS Targeted Promotion Programme can help nuclear tech adoption in potential sectors

ALOR SETAR: The Technology Preview and Showcase (TPS) of the Targeted Promotion Programme will help increase the level of adoption of nuclear technology in potential sectors.

Science, Technology and Innovation Ministry (MOSTI) secretary-general Datuk Ts. Dr. Aminuddin Hassim said the programme was also able to increase interest in learning Science, Technology, Engineering and Mathematics (STEM).

“TPS is one of the ongoing platforms of the Malaysian Nuclear Agency (Nuklear Malaysia) in the framework of promoting peaceful and safe nuclear technology products, services and training to the people and industry.

“Through this programme, the research and development results from Nuklear Malaysia researchers can be highlighted across various fields such as the application of nuclear technology in the agro-agriculture sector, radiation processing technology, industrial applications, environmental management, medicine applications, radiation health and safety, nuclear engineering and training,“ he said.

He was speaking the TPS Targeted Promotion Programme Series 2 and launch of the Nuclear Paddy Gallery by the Raja Muda of Kedah Tengku Sarafudin Badlishah Sultan Sallehuddin at the Kedah Paddy Museum near here today.

According to Aminuddin, visitors to the Kedah Paddy Museum will have the opportunity to obtain information and (find out) the role of Nuklear Malaysia in the production of the new paddy seed variety, NMR 152, throughout the two days of the programme (June 13 and 14).

He added that through the MOSTI Strategic Research Fund (SRF) project, two more new national paddy varieties are targeted to be produced by the end of 2026 using advanced drip irrigation.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings